Cargando…
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms
Activated macrophages contribute to the pathogenesis of vascular disease. Vein graft failure is a major clinical problem with limited therapeutic options. PCSK9 (proprotein convertase subtilisin/kexin 9) increases low-density lipoprotein (LDL)-cholesterol levels via LDL receptor (LDLR) degradation....
Autores principales: | Katsuki, Shunsuke, K. Jha, Prabhash, Lupieri, Adrien, Nakano, Toshiaki, Passos, Livia S.A., Rogers, Maximillian A., Becker-Greene, Dakota, Le, Thanh-Dat, Decano, Julius L., Ho Lee, Lang, Guimaraes, Gabriel C., Abdelhamid, Ilyes, Halu, Arda, Muscoloni, Alessandro, V. Cannistraci, Carlo, Higashi, Hideyuki, Zhang, Hengmin, Vromman, Amélie, Libby, Peter, Keith Ozaki, C., Sharma, Amitabh, Singh, Sasha A., Aikawa, Elena, Aikawa, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973449/ https://www.ncbi.nlm.nih.gov/pubmed/36263780 http://dx.doi.org/10.1161/CIRCRESAHA.121.320056 |
Ejemplares similares
-
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9
por: Melendez, Quantil M., et al.
Publicado: (2020) -
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review
por: Wu, Na-Qiong, et al.
Publicado: (2022) -
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
por: Schulz, Rainer, et al.
Publicado: (2015) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017) -
Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studies
por: Ferri, Nicola, et al.
Publicado: (2020)